Would the trial be allowed to continue to the next cohort (4) without good reason? IE a drop in viral load. Optimal therapeutic dose is one of the secondary endpoints. It's working or the trial would already be halted.
BLT.AX says CEO and Managing Director Dr Peter French Resigned, page-67
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)